Abciximab treatment modalities for thromboembolic events related to aneurysm coiling

Neurosurgery

Volumn 67, Issue SUPPL. 2, 2010, Pages

  Aggour, Mohamed ^a   Pierot, Laurent ^a   Kadziolka, Krisztof ^a   Gomis, Philippe ^a   Graftieaux, Jean Pierre ^a  

^a HÔPITAL MAISON BLANCHE   (France)

Author keywords

Abciximab; Aneurysm; Coiling; Complications; Embolization; Endovascular; Thromboembolic

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; COIL EMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION; RETROSPECTIVE STUDY; SCORING SYSTEM; THROMBOLYSIS IN MYOCARDIAL INFARCTION FLOW GRADE; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; THROMBOEMBOLISM;

EID: 78650615755     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e3181f8d1db     Document Type: Article

References (20)

1. Henkes H, Fischer S, Weber W, Miloslavski E, Brew S, Kuhne D. Endovascular coil occlusion of 1811 intracranial aneurysms: Early angiographic and clinical results. Neurosurgery. 2004;54:(2)268-285.
2. Pierot L, Bonafé A, Bracard S, Leclerc X; French Matrix Registry Investigators. Endovascular treatment of intracranial aneurysms with matrix detachable coils: Immediate posttreatment results from a prospective multicenter registry. AJNR Am J Neuroradiol. 2006;27(8):1693-1699.
3. Pierot L, Spelle L, Vitry F; ATENA Investigators. Immediate clinical outcome of patients harboring unruptured intracranial aneurysms treated by endovascular approach: Results of the ATENA study. Stroke. 2008;39(9):2497-2504.
4. Gallas S, Pasco A, Cottier JP, et al. A multicenter study of 705 ruptured intracranial aneurysms treated with Guglielmi detachable coils. AJNR Am J Neuroradiol. 2005;26:(7)1723-1731.
5. Pelz DM, Lownie SP, Fox AJ. Thromboembolic events associated with treatment of cerebral aneurysms with Guglielmi detachable coils. AJNR Am J Neuroradiol. 1998;19(8):1541-1547.
6. Workman MJ, Cloft HJ, Tong FC, et al. Thrombus formation at the neck of cerebral aneurysms during treatment with Guglielmi detachable coils. AJNR Am J Neuroradiol. 2002;23(9):1568-1576.
7. Cronqvist M, Pierot L, Boulin C, Cognard C, Castaings L, Moret J. Local intraarterial fibrinolysis of thromboemboli occurring during endovascular treatment of intracerebral aneurysm: A comparison of anatomic results and clinical outcome. AJNR Am J Neuroradiol. 1998;19(1):157-165.
8. Debrun GM, Vinuela FV, Fox AJ. Aspirin and systemic heparinization in diagnostic and interventional neuroradiology. AJNR Am J Neuroradiol. 1982;39(1):337-340.
9. Alexander MJ, Duckwiler GR, Gobin YO, Vinuela F. Management of intraprocedural arterial thrombus in cerebral aneurysm embolization with abciximab: Technical case report. Neurosurgery. 2002;50(4):899-902.
10. Ng PP, Phatouros CC, Khangure S. Use of glycoprotein IIb-IIIa inhibitor for a thromboembolic complication during Guglielmi detached coil treatment of an acutely ruptured aneurysm. AJNR Am J Neuroradiol. 2001;22(9):1761-1763.
11. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC investigation. N Engl J Med. 1994;330(14):956-961.
12. Reverter JC, Beguin S, Kessels H, Kumar R, Jemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by themouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis". J Clin Invest. 1996;98(3):863-874.
13. Topol EJ, Byzova TV, Plow EF. Platelet GPIIb-IIIa blockers. Lancet. 1999; 353(9148):227-231.
14. Aviv RI, O'Neill R, Patel MC, Colquhoun IR. Abciximab in patients with ruptured intracranial aneurysms. AJNR Am J Neuroradiol. 2005;26(7):1744-1750.
15. Park JH, Kim JE, Sheen SH, et al. Intraarterial abciximab for treatment of thromboembolism during coil embolization of intracranial aneurysms: Outcome and fatal hemorrhagic complications. J Neurosurg. 2008;108(3):450-457.
16. Song JK, Niimi Y, Fernandez PM, et al. Thrombus formation during intracranial aneurysm coil placement: Treatment with intra-arterial abciximab. AJNR Am J Neuroradiol. 2004;25(7):1147-1153.
17. Mounayer C, Piotin M, Baldi S, Spelle L, Moret J. Intraarterial administration of Abciximab for thromboembolic events occurring during aneurysm coil placement. AJNR Am J Neuroradiol. 2003;24(10):2039-2043.
18. Velat GJ, Burry MV, Eskioglu E, Dettorre RR, Firment CS, Mericle RA. The use of abciximab in the treatment of acute cerebral thromboembolic events during neuroendovascular procedures. Surg Neurol. 2006;65(4):352-358.
19. Jones RG, Davagnanam I, Colley S, West RJ, Yates DA. Abciximab for treatment of thromboembolic complications during endovascular coiling of intracranial aneurysms. AJNR Am J Neuroradiol. 2008;29(10):1925-1929.
20. Ries T, Siemonsen S, Grzyska U, Zeumer H, Fiehler J. Abciximab is a safe rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization. Stroke. 2009;40(5):1750-1757.